Your session is about to expire
← Back to Search
Diagnostic Test
Blood Test Assay for FPIES
N/A
Waitlist Available
Led By Mohamad El Zaatari, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 7 weeks from the first blood trial, on average 11 weeks
Awards & highlights
Study Summary
This trial is testing a new blood assay to see if it can identify safe foods for people with food protein-induced enterocolitis syndrome (FPIES).
Eligible Conditions
- Food Protein-Induced Enterocolitis Syndrome
- Allergy
- Pediatric Disorders
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 7 weeks from the first blood trial, on average 11 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 7 weeks from the first blood trial, on average 11 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Negative Predictive Value (NPV), Defined as the Percentage of Test-predicted Safe Foods That Are Actually Safe Foods.
Secondary outcome measures
Positive Predictive Value (PPV), Defined as the Percentage of Test-predicted Unsafe Foods That Are Actually Unsafe Foods.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Blood test with assaysExperimental Treatment1 Intervention
10 participants with FPIES exhibiting reactions to more than 2 foods will be recruited.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Blood test assay
2019
N/A
~10
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,810 Previous Clinical Trials
6,385,095 Total Patients Enrolled
Mohamad El Zaatari, PhDPrincipal InvestigatorUniversity of Michigan
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Blood test with assays
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger